← All companies
MDLN
Medline Inc.
$40.47
+1.35 +3.45%
Key statistics
from XBRL data in SEC filingsMarket cap
$33.4B
Revenue (TTM)
$28.4B
Net income (TTM)
$1.16T
EPS (TTM)
$-0.01
P/E ratio
—
Dividend yield
—
Free cash flow
$1.30B
Cash
$2.24B
Total assets
$39.0B
Gross margin
26.4%
52-week range
$32.82 – $50.88
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change
Jul 9, 2026
8-K
Shareholder vote results
Jun 12, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Jun 2, 2026
10-Q
Quarter ended 2026-03-28
May 6, 2026
8-K
Results of operations (earnings release)
May 6, 2026
10-K
Fiscal year ended 2025-12-31
Feb 25, 2026
8-K
Results of operations (earnings release)
Feb 25, 2026
8-K
Entered a material agreement; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events
Dec 22, 2025
Other filings
4
Jun 17, 2026
4
Jun 17, 2026
4
Jun 17, 2026
4
Jun 17, 2026
4
Jun 17, 2026
4
Jun 17, 2026
4
Jun 17, 2026
4
Jun 17, 2026
144
Jun 16, 2026
4
Jun 15, 2026
4
Jun 15, 2026
4
Jun 15, 2026
4
Jun 9, 2026
4
Jun 1, 2026
4
Jun 1, 2026
4
Jun 1, 2026
4
Jun 1, 2026
4
May 26, 2026
4
May 26, 2026
424B4
May 26, 2026
4
May 26, 2026
EFFECT
May 21, 2026
S-1MEF
May 21, 2026
CORRESP
May 20, 2026
S-1
May 20, 2026
SCHEDULE 13G/A
May 15, 2026
SCHEDULE 13G/A
May 7, 2026
SCHEDULE 13G/A
May 6, 2026
SCHEDULE 13G/A
May 1, 2026
ARS
Apr 23, 2026
DEFA14A
Apr 23, 2026
DEF 14A
FORM DEF 14A
Apr 23, 2026